103 related articles for article (PubMed ID: 8692995)
1. Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptors.
Fisher CE; Sutherland JA; Krause JE; Murphy JR; Leeman SE; vanderSpek JC
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7341-5. PubMed ID: 8692995
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxic properties and effects on early and late gene induction of a chimeric diphtheria toxin-leukemia-inhibitory factor protein.
Negro A; Skaper SD
Eur J Biochem; 1996 Oct; 241(2):507-15. PubMed ID: 8917449
[TBL] [Abstract][Full Text] [Related]
3. Production, characterization and cytotoxic properties of a diphtheria toxin-ciliary neurotrophic factor fusion protein.
Negro A; Skaper SD
Protein Eng; 1995 Feb; 8(2):175-83. PubMed ID: 7630888
[TBL] [Abstract][Full Text] [Related]
4. Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Murphy JR; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom TB
Biochem Soc Symp; 1987; 53():9-23. PubMed ID: 2847744
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
[TBL] [Abstract][Full Text] [Related]
6. Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats.
Wiley RG; Lappi DA
Neurosci Lett; 1997 Jul; 230(2):97-100. PubMed ID: 9259473
[TBL] [Abstract][Full Text] [Related]
7. Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein.
Jean LF; Murphy JR
Protein Eng; 1991 Dec; 4(8):989-94. PubMed ID: 1817263
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cells.
Chadwick DE; Williams DP; Niho Y; Murphy JR; Minden MD
Leuk Lymphoma; 1993 Oct; 11(3-4):249-62. PubMed ID: 7505148
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation.
Wen ZL; Tao X; Lakkis F; Kiyokawa T; Murphy JR
J Biol Chem; 1991 Jul; 266(19):12289-93. PubMed ID: 1648090
[TBL] [Abstract][Full Text] [Related]
10. Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells.
Kiyokawa T; Williams DP; Snider CE; Strom TB; Murphy JR
Protein Eng; 1991 Apr; 4(4):463-8. PubMed ID: 1881872
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells.
Vigna SR; Bowden JJ; McDonald DM; Fisher J; Okamoto A; McVey DC; Payan DG; Bunnett NW
J Neurosci; 1994 Feb; 14(2):834-45. PubMed ID: 7507985
[TBL] [Abstract][Full Text] [Related]
12. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.
Huang RR; Yu H; Strader CD; Fong TM
Biochemistry; 1994 Mar; 33(10):3007-13. PubMed ID: 7510519
[TBL] [Abstract][Full Text] [Related]
13. Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15.
vanderSpek JC; Sutherland J; Sampson E; Murphy JR
Protein Eng; 1995 Dec; 8(12):1317-21. PubMed ID: 8869645
[TBL] [Abstract][Full Text] [Related]
14. Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain.
Benoliel R; Eliav E; Mannes AJ; Caudle RM; Leeman S; Iadarola MJ
Pain; 1999 Feb; 79(2-3):243-53. PubMed ID: 10068170
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hybrid toxin with dual enzymatic activities. Potential use in preparing highly effective immunotoxins.
Li BY; Ramakrishnan S
J Biol Chem; 1994 Jan; 269(4):2652-8. PubMed ID: 8300596
[TBL] [Abstract][Full Text] [Related]
16. Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4.
Lakkis F; Landgraf B; Wen Z; Strom TB; Murphy JR
Protein Eng; 1992 Apr; 5(3):241-8. PubMed ID: 1409544
[TBL] [Abstract][Full Text] [Related]
17. The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389IL-2.
Hu HY; Huynh PD; Murphy JR; vanderSpek JC
Protein Eng; 1998 Sep; 11(9):811-7. PubMed ID: 9796831
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein.
Williams DP; Parker K; Bacha P; Bishai W; Borowski M; Genbauffe F; Strom TB; Murphy JR
Protein Eng; 1987 Dec; 1(6):493-8. PubMed ID: 3334101
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen.
Brown JG; Almond BD; Naglich JG; Eidels L
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8184-8. PubMed ID: 8367482
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
